Close Menu

immune repertoire sequencing

NEW YORK (GenomeWeb) – CareDx, formerly called XDx, said late Wednesday that it has reached an agreement to acquire transplant diagnostic company ImmuMetrix for an undisclosed amount.

NEW YORK (GenomeWeb News) – Adaptive Biotechnologies today announced it raised $105 million in private funding, which will allow it to expand its immunosequencing research platform and clinical diagnostic products.

NEW YORK (GenomeWeb News) – Adaptive Biotechnologies today said that it has received a $2.53 million Phase II Small Business Innovation Research grant to support its adaptive immune system testing technology.

NEW YORK (GenomeWeb News) – Sequenta has gained the exclusive rights to iRepertoire's IP related to methods of immune cell sequencing for minimal residual disease testing, the two companies said today.

NEW YORK (GenomeWeb News) – A team at the Fred Hutchinson Cancer Research Center has won $4.4 million in funding from the National Cancer Institute to use RNA sequencing to study proteins that may be involved in the body's immune response to cancer, the center said on Monday.

The story has been updated to provide additional details and comments from Adaptive Biotechnologies' CEO, Chad Robins.

NEW YORK (GenomeWeb News) – Adaptive Biotechnologies announced today a deal with Biogen Idec aimed at autoimmune disease biomarkers.

NEW YORK (GenomeWeb News) – Sequenta said today it has received CLIA certification for a clinical test based on in its immune repertoire sequencing-based technology called LymphoSight.

NEW YORK (GenomeWeb News) – A Rockefeller University researcher plans to use a $1.3 million grant from the National Institutes of Health to develop a novel method for applying high-throughput sequencing to the study of human immune system function.

NEW YORK (GenomeWeb News) – Atreca today announced it has licensed immune repertoire capture technology from Stanford University, which the biopharmaceutical company will develop for a broad range of applications.

Pages

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.